Literature DB >> 4842984

Mechanism responsible for the cardiovascular depressant. Effect of protamine sulfate.

M A Fadali, M Ledbetter, C A Papacostas, L J Duke, G M Lemole.   

Abstract

The mechanism of protamine-induced hypotension and bradycardia was investigated in anesthetized, heparinized dogs. Several groups of animals with intact circulation were studied for their responses to protamine under control conditions and following the administration of various pharmacological agents. The parameters observed include femoral arterial pressure (FAP), central venous pressure (CVP), left ventricular pressure (LVP) and its rate of rise (dp/dt), left ventricular contractile element velocity of shortening (Vce), maximal Vce (V max) and cardiac output (CO). Various groups were studied under the following pharmacological conditions: autonomic cholinergic blockade by atropine; alpha and beta adrenergic receptor blockade using phenoxybenzamine and propranolol respectively; ganglionic and adrenal medullary block using hexamethonium, and depletion of endogenous histamine by means of compound 48/80. Another group was placed on total cardiopulmonary bypass thus isolating the heart from the peripheral circulation. The effect of protamine on the vascular tree alone was then observed by monitoring FAP before and after protamine administration. The findings indicate that the cardiovascular effects of protamine are produced by a direct effect on the myocardium and vascular tree.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4842984      PMCID: PMC1343644          DOI: 10.1097/00000658-197408000-00018

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

1.  EFFECT OF PROTAMINE SULPHATE ON THE TRANSMISSION PROCESSES IN PERIPHERAL SYMPATHETIC GANGLIA.

Authors:  E MINKER; M KOLTAI
Journal:  Acta Physiol Acad Sci Hung       Date:  1964

2.  The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine.

Authors:  W S EGERTON; C L ROBINSON
Journal:  Lancet       Date:  1961-09-16       Impact factor: 79.321

3.  Studies on the toxicology of a histamine liberator, compound 48-80.

Authors:  C A PAPACOSTAS; E R LOEW; G B WEST
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-07-01

4.  The neutralization of heparin by protamine in extracorporeal circulation.

Authors:  F GERBODE; R HURT; J J OSBORN; H A PERKINS
Journal:  J Thorac Surg       Date:  1956-11

5.  Compound 48/80: a potent histamine liberator.

Authors:  W D M PATON
Journal:  Br J Pharmacol Chemother       Date:  1951-09

6.  Quantification of the contractile state of the intact human heart. Maximal velocity of contractile element shortening determined by the instantaneous relation between the rate of pressure rise and pressure in the left ventricle during isovolumic systole.

Authors:  D T Mason; J F Spann; R Zelis
Journal:  Am J Cardiol       Date:  1970-09       Impact factor: 2.778

7.  Total cardiopulmonary bypass, myocardial contractility, and the administration of protamine sulfate.

Authors:  A Gourin; R L Streisand; J H Stuckey
Journal:  J Thorac Cardiovasc Surg       Date:  1971-01       Impact factor: 5.209

8.  Cardiovascular effects of protamine sulfate.

Authors:  B S Goldman; J Joison; W G Austen
Journal:  Ann Thorac Surg       Date:  1969-05       Impact factor: 4.330

9.  Protamine sulfate administration and the cardiovascular system.

Authors:  A Gourin; R L Streisand; J K Greineder; J H Stuckey
Journal:  J Thorac Cardiovasc Surg       Date:  1971-08       Impact factor: 5.209

  9 in total
  3 in total

Review 1.  Anticoagulants in anaesthesia.

Authors:  P J Stow; F A Burrows
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

2.  Protamine induced arterial hypoxaemia: the relationship to hypoxic pulmonary vasoconstriction.

Authors:  Y D Kim; R Michalik; D E Lees; M Jones; S Hanowell; T E Macnamara
Journal:  Can Anaesth Soc J       Date:  1985-01

3.  Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models.

Authors:  Joanna Miklosz; Bartlomiej Kalaska; Piotr Podlasz; Małgorzata Chmielewska-Krzesińska; Miłosz Zajączkowski; Adam Kosiński; Dariusz Pawlak; Andrzej Mogielnicki
Journal:  Pharmaceutics       Date:  2021-03-09       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.